成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>Angiogenesis>BTK inhibitors>CNX-774
CNX-774
  • CNX-774

CNX-774 NEW

Price $34 $48 $80
Package 1mg 2mg 5mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-12

Product Details

Product Name: CNX-774 CAS No.: 1202759-32-7
Purity: 99.11% Supply Ability: 10g
Release date: 2024/11/12

Product Introduction

Bioactivity

名稱CNX-774
描述CNX-774 is a highly specific, irreversible, and orally active BTK inhibitor (IC50<1 nM).
激酶實驗In vitro kinase assays: The p38α and p38β are assayed in 25 mM Tris-HCl, pH 7.5, containing 0.1 mM EGTA, with myelin basic protein (0.33 mg/mL) as substrate. Assays are performed either manually for 10 minutes at 30 °C in 50 μL incubations using [γ-33P]ATP, or with a Biomek 2000 Laboratory Automation Workstation in a 96-well format for 40 minutes at ambient temperature in 25 μL incubations using [γ-33P]ATP. The concentrations of ATP and magnesium acetate are 0.1 mM and 10 mM respectively. All assays are initiated with MgATP. Manual assays are terminated by spotting aliquots of incubation on to phosphocellulose paper, followed by immersion in 50 mM phosphoric acid. Robotic assays are terminated by the addition of 5 μL of 0.5 M phosphoric acid before spotting aliquots on to P30 filter mats. All papers are then washed four times in 50 mM phosphoric acid to remove ATP, once in acetone (manual incubations) or methanol (robotic incubations), and then dried and counted for radioactivity.
存儲條件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度Ethanol : 2 mg/mL (4.0 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 93 mg/mL (186.2 mM)
關鍵字Bruton tyrosine kinase | Btk | CNX-774 | B-cell | BCR | Inhibitor | inhibit | CNX774 | autoimmune
相關產品evobrutinib | (±)-Zanubrutinib | CP-547632 | BMS-986142 | Edralbrutinib | Sunvozertinib | Ibrutinib | IBT6A | Orelabrutinib | Atuzabrutinib | Remibrutinib | CGI-1746
相關庫高選擇性抑制劑庫 | 經典已知活性庫 | 酪氨酸激酶分子庫 | 激酶抑制劑庫 | 抑制劑庫 | NO PAINS 化合物庫 | 腫瘤免疫治療小分子化合物庫 | 口服活性化合物庫 | 已知活性化合物庫 | 共價抑制劑庫

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$1.00/100g
VIP5Y
Career Henan Chemical Co
2019-12-20
$99.00/1EA
Amikon Limited
2018-08-31
$2.00/1kg
VIP7Y
Career Henan Chemical Co
2018-12-24
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY